Showing results (281-290 of 583) with videos related to
Sort By:
Pageof 59
Journal of Gastroenterology|August 6, 2011
Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapyMasaru Morita, Ryuichi Kumashiro, Yuichi Hisamatsu, et al.British Journal of Cancer|February 27, 2020
Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancerHideaki Bando, Yoshinori Kagawa, Takeshi Kato, et al.Oncotarget|January 17, 2019
Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancerTomohiro Shibata, Eriko Tokunaga, Satoshi Hattori, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 17, 2025
Clinicopathological significance of JAK2, STAT3, and STAT4 expression in patients with gastric solid-type poorly differentiated adenocarcinoma: a retrospective studyShinya Umekita, Daisuke Kiyozawa, Hitoshi Honma, et al.Surgical Case Reports|June 26, 2023
Combined treatment with surgery and immune checkpoint inhibitor extended survival in a case of gastric intramural metastasis from esophageal cancer: a case reportAyako Wakasugi, Yasue Kimura, Keita Natsugoe, et al.Asian Journal of Endoscopic Surgery|September 20, 2023
Tele-robotic distal gastrectomy with lymph node dissection on a cadaverYuma Ebihara, Satoshi Hirano, Yo Kurashima, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 3, 2015
Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomyKohei Shitara, Keisho Chin, Takaki Yoshikawa, et al.European Journal of Cancer (Oxford, England : 1990)|February 9, 2006
The association between Akt activation and resistance to hormone therapy in metastatic breast cancerEriko Tokunaga, Akemi Kataoka, Yasue Kimura, et al.Cancer Treatment Reviews|April 12, 2020
Imaging and clinical correlates with regorafenib in metastatic colorectal cancerKhurum Khan, Stefano Cascinu, David Cunningham, et al.Cancer Science|October 10, 2013
Podoplanin is expressed at the invasive front of esophageal squamous cell carcinomas and is involved in collective cell invasionYuichiro Nakashima, Keiji Yoshinaga, Hiroyuki Kitao, et al.Pageof 59